• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌基因在胃肠道癌症中的作用。

The role of oncogenes in gastrointestinal cancer.

作者信息

Pappou Emmanouil P, Ahuja Nita

机构信息

Department of Surgery The Johns Hopkins University Baltimore, MD.

出版信息

Gastrointest Cancer Res. 2010 Nov(Suppl 1):S2-S15.

PMID:21472044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3047044/
Abstract

Oncogene research over the last century has been one of the major advances in understanding the molecular biology of malignant disease. Oncogenes are a structurally and functionally heterogeneous group of genes, whose protein products act pleiotropically and affect multiple complex regulatory cascades within the cell. They regulate cell proliferation, growth, and differentiation, as well as control of the cell cycle and apoptosis. The products of oncogenes include growth factors, growth factor receptors, signal transducers, transcription factors, and apoptosis regulators, as well as chromatin remodelers. Several distinct mechanisms have been described for the conversion of proto-oncogenes to active oncogenes. Quantitative forms of oncogene activation include multiplication (gene amplification) or translocation to an active chromatin domain that brings a growth-regulatory gene under the control of a different promoter, causing inappropriate expression of the gene. Qualitative forms include either point mutations or the production of a novel product from a chimeric gene. Further understanding of the molecular mechanisms by which oncogenes regulate normal development and tumorigenesis may lead to novel concepts in the diagnosis and treatment of cancer in humans. In this review, we focus on the role of selected oncogenes in gastrointestinal cancer.

摘要

上个世纪的癌基因研究是理解恶性疾病分子生物学方面的重大进展之一。癌基因是一组在结构和功能上具有异质性的基因,其蛋白质产物具有多效性,可影响细胞内多个复杂的调控级联反应。它们调节细胞增殖、生长和分化,以及细胞周期和细胞凋亡的控制。癌基因的产物包括生长因子、生长因子受体、信号转导子、转录因子和凋亡调节因子,以及染色质重塑因子。已经描述了几种将原癌基因转化为活性癌基因的不同机制。癌基因激活的定量形式包括倍增(基因扩增)或易位至活性染色质结构域,使生长调节基因受不同启动子控制,导致该基因表达异常。定性形式包括点突变或嵌合基因产生新产物。对癌基因调节正常发育和肿瘤发生的分子机制的进一步了解可能会带来人类癌症诊断和治疗的新概念。在本综述中,我们重点关注特定癌基因在胃肠道癌中的作用。

相似文献

1
The role of oncogenes in gastrointestinal cancer.癌基因在胃肠道癌症中的作用。
Gastrointest Cancer Res. 2010 Nov(Suppl 1):S2-S15.
2
Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.作为终末造血细胞分化的正负调节因子的分化初级反应基因和原癌基因。
Stem Cells. 1994 Jul;12(4):352-69. doi: 10.1002/stem.5530120402.
3
Steroid hormone regulation of nuclear proto-oncogenes.类固醇激素对核原癌基因的调控。
Endocr Rev. 1993 Dec;14(6):659-69. doi: 10.1210/edrv-14-6-659.
4
[Oncogenic transcription factors as splicing regulators].[作为剪接调节因子的致癌转录因子]
Med Sci (Paris). 2004 Nov;20(11):1014-9. doi: 10.1051/medsci/200420111014.
5
Role of proto-oncogene activation in carcinogenesis.原癌基因激活在致癌作用中的作用。
Environ Health Perspect. 1992 Nov;98:13-24. doi: 10.1289/ehp.929813.
6
Molecular events in lung cancer.肺癌中的分子事件。
Lung Cancer. 1995 Jun;12 Suppl 2:S3-15. doi: 10.1016/s0169-5002(10)80002-9.
7
Proto-oncogenes in development and cancer.发育与癌症中的原癌基因。
Am J Reprod Immunol. 1991 Apr;25(3):129-32. doi: 10.1111/j.1600-0897.1991.tb01080.x.
8
Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.致癌机制:癌基因、转录增强子和生长因子的作用。
Anticancer Res. 1985 Sep-Oct;5(5):485-98.
9
Oncogenes in human leukemias.人类白血病中的癌基因。
Acta Haematol. 1987;78 Suppl 1:2-10. doi: 10.1159/000205895.
10
How are cancer associated genes activated or inactivated?
Eur J Cancer. 1992;28(1):248-51. doi: 10.1016/0959-8049(92)90425-2.

引用本文的文献

1
Anti-Tumor Potential of Frankincense Essential Oil and Its Nano-Formulation in Breast Cancer: An In Vivo and In Vitro Study.乳香精油及其纳米制剂在乳腺癌中的抗肿瘤潜力:一项体内和体外研究
Pharmaceutics. 2025 Mar 27;17(4):426. doi: 10.3390/pharmaceutics17040426.
2
Inflammatory Fibroid Polyp (Vanek's Tumor): A Retrospective Multicentric Analysis of 67 Cases.炎性纤维性息肉(瓦内克瘤):67例病例的回顾性多中心分析
Cancers (Basel). 2025 Apr 2;17(7):1209. doi: 10.3390/cancers17071209.
3
Determinants of gastric cancer immune escape identified from non-coding immune-landscape quantitative trait loci.从非编码免疫景观数量性状基因座鉴定的胃癌免疫逃逸决定因素。
Nat Commun. 2024 May 21;15(1):4319. doi: 10.1038/s41467-024-48436-5.
4
A functional analysis of omic network embedding spaces reveals key altered functions in cancer.对组学网络嵌入空间的功能分析揭示了癌症中关键改变的功能。
Bioinformatics. 2023 May 4;39(5). doi: 10.1093/bioinformatics/btad281.
5
Role of EFNA1 SNP (rs12904) in Tumorigenesis and Metastasis of Colorectal Cancer: A Bioinformatic Analysis and HRM SNP Genotyping Verification.EFNA1 SNP(rs12904) 在结直肠癌发生和转移中的作用:生物信息学分析和 HRM SNP 基因分型验证。
Asian Pac J Cancer Prev. 2022 Oct 1;23(10):3523-3531. doi: 10.31557/APJCP.2022.23.10.3523.
6
Overexpression of Nedd9 is a prognostic marker of human gastric cancer.Nedd9的过表达是人类胃癌的一个预后标志物。
Med Oncol. 2014 Jul;31(7):33. doi: 10.1007/s12032-014-0033-5. Epub 2014 Jun 7.
7
Genetic unraveling of colorectal cancer.结直肠癌的基因解析
Tumour Biol. 2014 Jun;35(6):5067-82. doi: 10.1007/s13277-014-1713-7. Epub 2014 Feb 27.
8
Identification of homogeneously staining regions in leukemia patients.白血病患者中均匀染色区域的鉴定。
J Res Med Sci. 2013 Apr;18(4):363-5.

本文引用的文献

1
RETRACTED: miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.撤回:miR-221和miR-222通过下调PTEN和TIMP3来调节TRAIL抗性并增强肿瘤发生能力。
Cancer Cell. 2009 Dec 8;16(6):498-509. doi: 10.1016/j.ccr.2009.10.014.
2
A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS.一种可通过与肿瘤细胞分离的因子传播的家禽肉瘤。
J Exp Med. 1911 Apr 1;13(4):397-411. doi: 10.1084/jem.13.4.397.
3
A TRANSMISSIBLE AVIAN NEOPLASM. (SARCOMA OF THE COMMON FOWL.).传染性禽类赘生物。(普通家禽的肉瘤。)
J Exp Med. 1910 Sep 1;12(5):696-705. doi: 10.1084/jem.12.5.696.
4
Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer.多因素分析分子改变预测结直肠癌患者接受 EGFR 靶向单克隆抗体的临床获益。
PLoS One. 2009 Oct 2;4(10):e7287. doi: 10.1371/journal.pone.0007287.
5
Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure.舒尼替尼治疗伊马替尼耐药胃肠间质瘤患者的分子靶向调节、显像及临床评估。
Clin Cancer Res. 2009 Sep 15;15(18):5902-9. doi: 10.1158/1078-0432.CCR-09-0482. Epub 2009 Sep 8.
6
MicroRNAs in Cancer.癌症中的微小RNA
Annu Rev Med. 2009;60:167-79. doi: 10.1146/annurev.med.59.053006.104707.
7
A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases.一项针对602例结肠癌病例中细胞周期蛋白D1表达与预后的队列研究。
Clin Cancer Res. 2009 Jul 1;15(13):4431-8. doi: 10.1158/1078-0432.CCR-08-3330. Epub 2009 Jun 23.
8
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.西妥昔单抗与化疗联合作为转移性结直肠癌的初始治疗方案
N Engl J Med. 2009 Apr 2;360(14):1408-17. doi: 10.1056/NEJMoa0805019.
9
American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.美国临床肿瘤学会临时临床意见:检测转移性结直肠癌患者的KRAS基因突变以预测抗表皮生长因子受体单克隆抗体治疗的反应
J Clin Oncol. 2009 Apr 20;27(12):2091-6. doi: 10.1200/JCO.2009.21.9170. Epub 2009 Feb 2.
10
A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer.一项随机 IIIB 期试验:比较化疗、贝伐单抗和帕尼单抗联合治疗与单纯化疗和贝伐单抗治疗转移性结直肠癌的疗效。
J Clin Oncol. 2009 Feb 10;27(5):672-80. doi: 10.1200/JCO.2008.19.8135. Epub 2008 Dec 29.